Basic Information
RNALocate ID: RLID:01001838
RNA Symbol: hsa-miR-154-5p
Localization: Mitochondrion
RNA Information
RNA Name: hsa-miR-154
RNA ID: miRBase:MIMAT0000452
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 21637849
Tissue/Cell Line: Skeletal muscle myoblasts
Method: ISH|qRT-PCR
Description: List of microRNA significantly detected in the mitochondrial mRNA at three increasing mtRNA inputs (1, 5 and 35 uL). Table S3 List of microRNA significantly detected (Cp<35) in the mitochondrial mRNA at the two highest mtRNA inputs (5 and 35 uL). Data are collected from Table 4 and S3.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:11001932 Exosome Brain tissue 23382797
RLID:11001933 Exosome Plasma 23663360
RLID-D:11000380 Microvesicle Fibroblasts|Mesenchymal stem cells
RLID-D:11001180 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-154-5p Oral squamous cell carcinoma MNDR-E-MI-17418
MNDR hsa-miR-154-5p Medulloblastoma MNDR-E-MI-17419
MNDR hsa-miR-154-5p High-grade serous ovarian carcinoma MNDR-E-MI-17420
MNDR hsa-miR-154-5p Ovarian clear cell carcinoma MNDR-E-MI-17421
MNDR hsa-miR-154-5p Uterine corpus endometrial carcinoma MNDR-E-MI-17422
MNDR hsa-miR-154-5p Estrogen-receptor positive breast cancer MNDR-E-MI-17423
MNDR hsa-miR-154-5p Estrogen-receptor negative breast cancer MNDR-E-MI-17424
MNDR hsa-miR-154-5p Progesterone-receptor positive breast cancer MNDR-E-MI-17425
MNDR hsa-miR-154-5p Progesterone-receptor negative breast cancer MNDR-E-MI-17426
MNDR hsa-miR-154-5p Her2-receptor positive breast cancer MNDR-E-MI-17427
MNDR hsa-miR-154-5p Breast cancer luminal MNDR-E-MI-17428
MNDR hsa-miR-154-5p Dermatomyositis MNDR-E-MI-17429
MNDR hsa-miR-154-5p Prostate cancer MNDR-E-MI-17430
MNDR hsa-miR-154-5p Gastric cancer MNDR-E-MI-17431
MNDR hsa-miR-154-5p Alzheimer disease MNDR-E-MI-17432
MNDR hsa-miR-154-5p Bladder cancer MNDR-E-MI-17433
MNDR hsa-miR-154-5p Dysautonomia familial MNDR-E-MI-17434
MNDR hsa-miR-154-5p Muscular dystrophy duchenne MNDR-E-MI-17435
MNDR hsa-miR-154-5p Facioscapulohumeral muscular dystrophy MNDR-E-MI-17436
MNDR hsa-miR-154-5p Head and neck cancer MNDR-E-MI-17437
MNDR hsa-miR-154-5p Huntington disease MNDR-E-MI-17438
MNDR hsa-miR-154-5p Lung cancer MNDR-E-MI-17439
MNDR hsa-miR-154-5p Endometrial cancer MNDR-E-MI-17440
MNDR hsa-miR-154-5p Parkinson disease MNDR-E-MI-17441
MNDR hsa-miR-154-5p Breast cancer MNDR-E-MI-17442
MNDR hsa-miR-154-5p Thyroid cancer MNDR-E-MI-17443
MNDR hsa-miR-154-5p Pituitary neoplasms MNDR-E-MI-17444
MNDR hsa-miR-154-5p Pancreatic cancer MNDR-E-MI-17445
MNDR hsa-miR-154-5p Melanoma MNDR-E-MI-17446
MNDR hsa-miR-154-5p Nephroblastoma MNDR-E-MI-17447
MNDR hsa-miR-154-5p Colon cancer MNDR-E-MI-17448
MNDR hsa-miR-154-5p Familial ovarian cancer MNDR-E-MI-17449
MNDR hsa-miR-154-5p Prostate adenocarcinoma MNDR-E-MI-17450
MNDR hsa-miR-154-5p Carcinoma ductal breast MNDR-E-MI-17451
MNDR hsa-miR-154-5p Balkan nephropathy MNDR-E-MI-17452
MNDR hsa-miR-154-5p Glioblastoma MNDR-E-MI-17453
MNDR hsa-miR-154-5p Astrocytoma MNDR-E-MI-17454
MNDR hsa-miR-154-5p Glioma MNDR-E-MI-17455
MNDR hsa-miR-154-5p Nemaline myopathy MNDR-E-MI-17456
MNDR hsa-miR-154-5p Amyotrophic lateral sclerosis MNDR-E-MI-17457
MNDR hsa-miR-154-5p Pancreatic ductal adenocarcinoma MNDR-E-MI-17458
MNDR hsa-miR-154-5p Meningioma MNDR-E-MI-17459
MNDR hsa-miR-154-5p Uterine cancer MNDR-E-MI-17460
MNDR hsa-miR-154-5p Gastric adenocarcinoma MNDR-E-MI-17461
MNDR hsa-miR-154-5p Cervical squamous cell carcinoma MNDR-E-MI-17462
MNDR hsa-miR-154-5p Bone-invasive pituitary adenoma MNDR-E-MI-17463
MNDR hsa-miR-154-5p Lung adenocarcinoma MNDR-E-MI-17464
MNDR hsa-miR-154-5p Adrenocortical carcinoma MNDR-E-MI-17465
MNDR hsa-miR-154-5p Thyroid carcinoma MNDR-E-MI-17466
MNDR hsa-miR-154-5p Ovarian carcinoma MNDR-E-MI-17467
MNDR hsa-miR-154-5p Bladder urothelial carcinoma MNDR-E-MI-17468
MNDR hsa-miR-154-5p Pancreatic adenocarcinoma MNDR-E-MI-17469
MNDR hsa-miR-154-5p Carcinoma renal cell MNDR-E-MI-17470
MNDR hsa-miR-154-5p Kidney renal papillary cell carcinoma MNDR-E-MI-17471
MNDR hsa-miR-154-5p Renal clear cell carcinoma MNDR-E-MI-17472
MNDR hsa-miR-154-5p Cholangiocarcinoma MNDR-E-MI-17473
MNDR hsa-miR-154-5p Esophageal cancer MNDR-E-MI-17474
MNDR hsa-miR-154-5p Synovial sarcoma MNDR-E-MI-17475
MNDR hsa-miR-154-5p Head and neck squamous cell carcinoma MNDR-E-MI-17476
MNDR hsa-miR-154-5p T acute lymphoblastic leukemia MNDR-E-MI-17477
MNDR hsa-miR-154-5p Acute t cell leukemia MNDR-E-MI-17478
MNDR hsa-miR-154-5p Breast invasive carcinoma MNDR-E-MI-17479
MNDR hsa-miR-154-5p Hepatocellular carcinoma MNDR-E-MI-17480
MNDR hsa-miR-154-5p Familiar ovarian carcinoma MNDR-E-MI-17481
MNDR hsa-miR-154-5p Neuroblastoma MNDR-E-MI-17482
MNDR hsa-miR-154-5p Colorectal cancer MNDR-E-MI-17483
MNDR hsa-miR-154-5p Nasopharynx carcinoma MNDR-E-MI-17484
MNDR hsa-miR-154-5p Nasopharyngeal cancer MNDR-E-MI-17485
MNDR hsa-miR-154-5p Prostatic neoplasms MNDR-E-MI-17486
MNDR hsa-miR-154-5p Polymyositis MNDR-E-MI-17487
MNDR hsa-miR-154-5p Non-alcoholic fatty liver disease MNDR-E-MI-17488
MNDR hsa-miR-154-5p Breast cancer her3+ negative MNDR-E-MI-17489
MNDR hsa-miR-154-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-17490
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CCND2 Homo sapiens RR00295032
TOP